For more information, get Portfolio Grader’s complete analysis of CCLP stock. Louis Navellier ... from InvestorPlace Media, http://investorplace.com/2016/05/5-stocks-with-poor-earnings-revisions-fve-rlgt-cdi-cytx-cclp/.
Patience is not a virtue for a weak stock market that wants more and wants it now. CYTX has declined from an intraday high of $8.44 on April 5th to its current price of about $4.80. While I am still bullish on the long term prospects of Cytori, …
Cytori Therapeutics, Inc. (NASDAQ: CYTX) entered into a definitive securities purchase ... with each unit consisting of one share of its Series A 3.6% convertible preferred stock, which shall be convertible into the Company's common stock
Cytori Therapeutics Inc. (NASDAQ: CYTX), Endo Health Solutions Inc. (NASDAQ ... This is now about 5-times normal trading volume and the stock hit a yearly high of $14.07 earlier in the day. This move took the market cap up to over …
The company now expects full year contract revenue to range between $275 million and $283 million, up from its prior outlook of $ ... events. CYTX closed Tuesday's trading at $2.10, down 0.47%. In after-hours, the stock was down …